112 related articles for article (PubMed ID: 1630006)
1. [Fundamentals of leukemia differentiation therapy].
Hozumi M
Rinsho Ketsueki; 1992 May; 33(5):561-72. PubMed ID: 1630006
[No Abstract] [Full Text] [Related]
2. [Experimental model for differentiation therapy of leukemia].
Hayashi M
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1009-15. PubMed ID: 8099785
[TBL] [Abstract][Full Text] [Related]
3. [Cell differentiation induction therapy in leukemia].
Tashima M; Sawada H; Okazaki T; Mochizuki T; Ishikura H; Izumi Y; Uchino H
Nihon Rinsho; 1986 Feb; 44(2):388-94. PubMed ID: 3517417
[No Abstract] [Full Text] [Related]
4. Selective antimetastatic drugs (review).
Giraldi T; Sava G
Anticancer Res; 1981; 1(3):163-74. PubMed ID: 7044264
[No Abstract] [Full Text] [Related]
5. [Differentiation--inducing therapy].
Kizaki M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():207-10. PubMed ID: 23133954
[No Abstract] [Full Text] [Related]
6. WEHI-3B D+ Y1 leukemia cells as a model system to assess the induction of differentiation in vivo.
Gamba-Vitalo C; Carman MD; Sartorelli AC
Cancer Commun; 1989; 1(3):157-65. PubMed ID: 2561737
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of DAAS derivatives and their enhancement of HL-60 leukemia cell differentiation.
Kim SH; Chung SY; Kim YW; Kim TS; Choi BG
Arch Pharm Res; 2008 Mar; 31(3):300-4. PubMed ID: 18409041
[TBL] [Abstract][Full Text] [Related]
8. Low-dose chemotherapy and differentiating agents.
Chomienne C
Baillieres Clin Haematol; 1991 Jan; 4(1):47-68. PubMed ID: 2039861
[No Abstract] [Full Text] [Related]
9. [Induction of the differentiation of tumor cells as an approach to tumor therapy].
Hozumi M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1349-57. PubMed ID: 2439010
[TBL] [Abstract][Full Text] [Related]
10. [A new concept: treatment using differentiation of the malignant cell in man].
Degos L
Bull Acad Natl Med; 1995 Nov; 179(8):1689-700. PubMed ID: 8717185
[TBL] [Abstract][Full Text] [Related]
11. [Structural changes of cell membrane and cell differentiation induction].
Honma Y
Nihon Rinsho; 1985 Apr; 43(4):706-8. PubMed ID: 3861893
[No Abstract] [Full Text] [Related]
12. Role of prostaglandins in regulation of erythroleukemic cell proliferation and differentiation.
Santoro MG
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():395-9. PubMed ID: 2936130
[No Abstract] [Full Text] [Related]
13. The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents.
Hirshaut Y; Weiss GH; Perry S
Cancer Res; 1969 Sep; 29(9):1732-40. PubMed ID: 5258874
[No Abstract] [Full Text] [Related]
14. [Aim of treatment in acute leukemia].
Senn HJ
Ther Umsch; 1969 Jul; 26(7):395-401. PubMed ID: 5257145
[No Abstract] [Full Text] [Related]
15. Potential applications of cytodifferentiation therapy in hematologic malignancies.
Breitman TR; Chen ZX; Takahashi N
Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
[TBL] [Abstract][Full Text] [Related]
16. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
Jing Y; Hellinger N; Xia L; Monks A; Sausville EA; Zelent A; Waxman S
Cancer Res; 2005 Sep; 65(17):7847-55. PubMed ID: 16140954
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based therapy for leukemia: a lesson from ATRA therapy.
Naoe T
Nagoya J Med Sci; 2001 Nov; 64(3-4):103-8. PubMed ID: 11820331
[TBL] [Abstract][Full Text] [Related]
18. Properties of antileukaemic drugs.
Brusamolino E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
[No Abstract] [Full Text] [Related]
19. Relevance of in vitro tests for predicting responsiveness to antitumor agents.
Kessel D
Natl Cancer Inst Monogr; 1971 Dec; 34():138-43. PubMed ID: 4946578
[No Abstract] [Full Text] [Related]
20. [Methods of determining blast cell sensitivity to chemical preparations in treating leukemias (a review of the literature)].
Evtukh VP
Vrach Delo; 1986 Aug; (8):42-6. PubMed ID: 3535253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
